Details of the Drug Formulaction

General Information of Drug Formulation (ID: F05485)

• Formulation Name: Dexlansoprazole 30 mg capsule
• Company: Takeda Pharmaceuticals America

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Dexlansoprazole	(DM1DBV5)	Erosive esophagitis	DA25.0	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Eisenoxyd	(E00585)	56841934	Colorant
FD&C blue no. 2	(E00446)	2723854	Colorant
Magnesium carbonate	(E00205)	11029	Adsorbent; Diluent
Polysorbate 80	(E00665)	Not Available	Dispersing agent; Emollient; Emulsifying agent; Plasticizing agent; Solubilizing agent; Surfactant; Suspending agent
Potassium chloride	(E00074)	4873	Tonicity agent
Saccharose	(E00091)	5988	Binding agent; Coating agent; Cryoprotectant; Diluent; Flavoring agent; Suspending agent; Viscosity-controlling agent
Silicon dioxide	(E00670)	Not Available	Anticaking agent; Opacifying agent; Viscosity-controlling agent
Talc	(E00520)	16211421	Anticaking agent; Diluent; Glidant; lubricant
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent
Triethyl citrate	(E00128)	6506	Plasticizing agent; Solvent